Stock Events

ProShares Ultra Nasdaq Biotechnology 2X Shares 

$63.76
10
+$0.57+0.89% Monday 20:00

Statistics

Day High
64.25
Day Low
62.49
52W High
69.56
52W Low
40.1
Volume
10,721
Avg. Volume
12,835
Mkt Cap
-
P/E Ratio
-
Dividend Yield
0.78%
Dividend
0.5

Upcoming

2
OCT
Dividend Payment
Decreased
 
23
DEC
Dividend Ex
Estimated
 
31
DEC
Dividend Payment
Estimated
 
20
MAR 25
Dividend Ex
Estimated
 
27
MAR 25
Dividend Payment
Estimated
 
26
JUN 25
Dividend Ex
Estimated
 
3
JUL 25
Dividend Payment
Estimated
 
25
SEP 25
Dividend Ex
Estimated
 
2
OCT 25
Dividend Payment
Estimated
 
20
DEC 25
Dividend Ex
Estimated
 

Dividends

0.78%Dividend Yield
Oct 24
$0.15
Jul 24
$0.26
Mar 24
$0.04
Dec 23
$0.04
Dec 22
$0.02
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
1,192.74%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BIB. It's not an investment recommendation.
Alphabet
74483
GOOGL
Apple
64892
AAPL
Microsoft
60484
MSFT
Amazon
55828
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
ProShares UltraShort Nasdaq Biotechnology -2x Shares
BIS
Mkt Cap0
ProShares UltraShort Nasdaq Biotechnology, offers inverse (-2x) daily performance of the NASDAQ Biotechnology Index, directly competing with BIB's 2x long strategy.
Direxion Daily S&P Biotech Bull 3X Shares
LABU
Mkt Cap0
Direxion Daily S&P Biotech Bull 3X Shares, offers 3x daily long leverage to the S&P Biotechnology Select Industry Index, competing in the leveraged biotech space.
Direxion Daily S&P Biotech Bear 3X Shares
LABD
Mkt Cap0
Direxion Daily S&P Biotech Bear 3X Shares, provides -3x daily short leverage to the same index as LABU, offering an inverse strategy in the leveraged biotech sector.
iShares Biotechnology
IBB
Mkt Cap0
iShares Nasdaq Biotechnology ETF, tracks the NASDAQ Biotechnology Index but without leverage, competing as a more traditional, non-leveraged alternative.
SPDR Biotech
XBI
Mkt Cap0
SPDR S&P Biotech ETF, tracks an equal-weighted index in the biotech sector, offering a diversified non-leveraged alternative.
VanEck Biotech
BBH
Mkt Cap0
VanEck Vectors Biotech ETF, provides exposure to companies in the biotech industry, competing as a non-leveraged investment option.
First Trust NYSE Arca Biotechnology Index Fund
FBT
Mkt Cap0
First Trust NYSE Arca Biotechnology Index Fund, tracks a modified equal-weighted index of biotech stocks, offering another non-leveraged alternative.
ALPS Medical Breakthroughs
SBIO
Mkt Cap0
ALPS Medical Breakthroughs ETF, focuses on small- and mid-cap biotechnology and pharmaceutical companies, offering targeted exposure within the biotech sector.
Invesco Biotechnology & Genome
PBE
Mkt Cap0
Invesco Dynamic Biotechnology & Genome ETF, uses a quantitative model to select biotech and genome companies, providing a unique strategy within the sector.
Virtus LifeSci Biotech Products
BBP
Mkt Cap0
Virtus LifeSci Biotech Products ETF, tracks an equal-weighted index of biotech companies with one or more drugs in Phase III clinical trials, offering focused exposure on late-stage biotech companies.

About

Miscellaneous
Investment Trusts/Mutual Funds
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
Show more...
CEO
Country
US
ISIN
US74347R2141

Listings

XNAS
US
BIB